基于数据挖掘技术及网络药理学探讨中药治疗输卵管性不孕用药规律及作用机制
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R271.14;R285

基金项目:

湖南中医药大学校级科研基金重点项目(2021XJJJ052)


Discussion on Medication Rules and Mechanism of Chinese Medicinals for Tubal Infertility Based on Data Mining and Network Pharmacology
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:基于数据挖掘技术和网络药理学探讨中药治疗输卵管性不孕(TI) 的用药规律及作用机制。 方法:计算机检索中国知网(CNKI)、万方数据知识服务平台(WF)、维普数据库(VIP)、PubMed等数据库, 时间选择2015年1月1日—2023年9月1日,纳入符合条件的中药治疗TI的相关文献。利用Excel软件统计中药 性味归经;采用R语言统计中药使用频次,并对使用频次排名前20的中药进行关联规则和聚类分析。选用聚 类分析得到的核心方,借助中药系统药理学数据库与分析平台(TCMSP) 获取核心方的有效成分及靶点,通过 UniPort数据库进行靶点校正,在GeneCards数据库、人类孟德尔遗传数据库(OMIM) 检索与TI相关的疾病基 因,然后进行交集分析获得共同基因,借助Cytoscape3.10.0获得核心靶点蛋白质-蛋白质相互作用(PPI) 网络 图。将药物-疾病交集靶点导入Metascape数据库进行基因本体(GO) 及京都基因与基因组百科全书(KEGG) 富集分析。采用Cytoscape3.10.0软件构建中药-药物成分-靶点-信号通路网络图。结果:共纳入方剂120首, 包含262味中药,中药总使用频次为1 480次,使用频次排名前20的中药有赤芍、当归、丹参、川芎、路路通 等。药性以温、寒、平性为主,药味以苦、甘、辛味居多,归经主要为肝、肾、脾经。关联规则分析得到三 棱-莪术、红花-当归等药物组合。聚类分析形成6个新的药物组合,第1类药物组合(莪术、三棱、路路通、 皂角刺、丹参) 可能为中药治疗TI的核心方。β-谷甾醇、槲皮素、木犀草素、隐丹参酮、漆黄素等是核心方 治疗TI的关键成分,这些成分可能作用于肿瘤坏死因子(TNF)、肿瘤蛋白53(TP53)、白细胞介素(IL) 6、 雌激素受体1(ESR1)、B淋巴细胞肿瘤2(BCL2) 等靶点,并通过癌症、缺氧诱导因子-1(HIF-1)、丝裂原 活化蛋白激酶(MAPK)、FoxO等信号通路发挥作用。结论:临床治疗TI多用行气活血、化瘀止痛类中药,核 心方可能通过癌症、HIF-1、MAPK及FoxO等信号通路参与调节细胞增殖、分化、炎症反应等过程,发挥对TI 的治疗作用。

    Abstract:

    Abstract: Objective: To discuss the medication rules and mechanism of Chinese medicinals for tubal infertility (TI) based on data mining and network pharmacology. Methods: The relevant literature on TI treated by Chinese medicinals were included by searching the China National Knowledge Infrastructure (CNKI),China Science Periodical Database( WF),China Science and Technology Journal Database( VIP),PubMed and other databases from January 1st,2015 to September 1st,2023. The nature,flavors and meridian entries were counted by Excel software; the use frequency of Chinese medicinals was counted by R language and the top 20 Chinese medicinals were given association rules analysis and cluster analysis. The core prescriptions based on cluster analysis were obtained and the effective ingredients and targets were worked out by using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP). The targets were corrected by UniPort database, the TI-related disease genes were researched on GeneCards database and Online Mendelian Inheritance in Man (OMIM) database, and the common genes were figured out by intersection analysis. Using Cytoscape 3.10.0,the protein-protein interaction (PPI) networks of core targets were obtained. The medicine-disease intersection targets were imported into Metascape for enrichment analysis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). The Chinese medicinals-component-target-signaling pathway networks were established by Cytoscape 3.10.0 software. Results:A total of 120 prescriptions were included, involving 262 Chinese medicinals. The Chinese medicinals were used for 1 480 times in total and the top 20 included Paeoniae Radix Rubra,Angelicae Sinensis Radix,Salviae Miltiorrhizae Radix et Rhizoma,Chuanxiong Rhizoma and Liquidambaris Fructus,etc. The Chinese medicinals were mainly warm, cold and neutral in nature, and bitter, sweet and acrid in flavor, and their main meridian entries were the liver, kidney and spleen. The association rules analysis suggested the medicinal combinations of Spargani Rhizoma-Curcumae Rhizoma and Carthami Flos-Angelicae Sinensis Radix, etc. The cluster analysis presented six new medicinal combinations, and the Class 1 medicinal combinations (Curcumae Rhizoma, Spargani Rhizoma, Liquidambaris Fructus,Gleditsiae Spina and Salviae Miltiorrhizae Radix et Rhizoma) could be the core prescription for treating TI by Chinese medicinals. The β-sitosterol,quercetin,luteolin,cryptotanshinone and fisetin were the critical ingredients of core prescription for TI and these ingredients may have an effect on the targets of tumor necrosis factor (TNF),tumor protein 53 (TP53), interleukin (IL) 6, estrogen receptor 1 (ESR1) and B-cell lymphoma-2 (BCL2) by signaling pathways in cancer, hypoxia inducible factor-1 (HIF-1), mitogen-activated protein kinase (MAPK) and FoxO. Conclusion:The Chinese medicinals for promoting qi and activating blood,and resolving stasis and relieving pain are mainly used for TI in clinical, and the core prescription may exert its curative effect on TI by playing a role in cells proliferation, cellular differentiation and inflammatory responses through signaling pathways in cancer, HIF-1, MAPK and FoxO.

    参考文献
    相似文献
    引证文献
引用本文

杨程卷,段梦琦,彭思嘉,谭枚秀.基于数据挖掘技术及网络药理学探讨中药治疗输卵管性不孕用药规律及作用机制[J].新中医,2025,57(4):156-164

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-03-03
  • 出版日期:
文章二维码